Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Sunmi Technology HK$908.7 million IPO
We advised Sunmi Technology on its IPO and HKEX listing
Oruka Therapeutics $700 million follow-on offering
We advised Oruka on the offering
Elea Data Centers acquisition by I Squared Capital
We advised Elea Data Centers and Piemonte Holding on the transaction
Bertelsmann agreement with Great Mountain Partners to combine BMG and Concord
We are advising Bertelsmann on the transaction
Shanghai Xizhi Technology HK$2.5 billion IPO
We advised Shanghai Xizhi Technology on its IPO and HKEX listing
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
HOF Capital consortium acquisition of Porsche's stakes in Bugatti Rimac and Rimac Group
We are advising HOF Capital on the transaction
Sumitomo Mitsui Trust Bank $3 billion senior notes offering
We advised SMTB on the update of its global MTN program and senior notes offering
Openly growth investment round
We advised Openly on the transaction